Sinopharm Tech Holdings Limited has scheduled a board meeting for Thursday, 24 September 2026. According to the company’s announcement to the Hong Kong Stock Exchange, directors will review and approve the audited annual results for the financial year ended 30 June 2026.

In addition to the results approval, the board will consider two capital-allocation items:

1. A proposal to defer payment of the annual preferred distribution on the company’s outstanding convertible preference shares. 2. A decision on whether to declare a final dividend on the ordinary shares.

The announcement was authorised by Executive Director Ms. Kwok Shuk Yi on behalf of the board, which currently consists of two executive directors and four independent non-executive directors.

The company stated that the notice will remain available on HKEX’s “Latest Listed Company Information” page and on Sinopharm Tech’s corporate website for at least seven days from its publication date of 11 September 2026.